Arterys
- Industry
- Medical Imaging AI
- Founded Year
- 2013
- Headquarters
- San Francisco, California, United States
- Employee Count
- 33
Key People
- Albert Hsiao - Founder
- Shreyas Vasanawala - Founder
- Timothy Henn - Chief Financial Officer
- Babak Rasolzadeh - VP of Product & Software Development
- John Axerio-Cilies - Chief Executive Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The founding team comprises experienced professionals with backgrounds in medical technology and entrepreneurship.
The founders, including Albert Hsiao and Shreyas Vasanawala, have extensive experience in medical imaging and technology, contributing to the company's innovative approach in the field.
- Clinical Need
-
Aspect: Very Strong
Summary: Arterys addresses critical challenges in radiology, such as workload management and diagnostic accuracy.
By integrating AI into medical imaging, Arterys provides solutions that enhance diagnostic precision and efficiency, meeting a significant clinical demand.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The medical imaging AI market is highly competitive, with numerous players and strategic partnerships.
Arterys faces competition from companies like Aidoc, Zebra Medical Vision, and MaxQ AI Ltd., all vying for market share in the AI-driven medical imaging sector.
- Technical Challenge
-
Aspect: Predictable
Summary: The technical challenges in developing AI for medical imaging are well-defined and manageable.
Arterys has successfully navigated technical hurdles, evidenced by multiple FDA clearances for its AI-powered imaging solutions.
- Patent
-
Aspect: Strong
Summary: Arterys holds a robust patent portfolio supporting its AI imaging technologies.
The company's patents provide a competitive edge, protecting its innovations in the medical imaging AI space.
- Financing
-
Aspect: Well-funded
Summary: Arterys has secured substantial funding from reputable investors.
With total funding of approximately $72.1 million, Arterys is well-positioned to continue its growth and development initiatives.
- Regulatory
-
Aspect: 510k/PMA
Summary: Arterys has achieved multiple FDA clearances for its AI products.
The company's success in obtaining regulatory approvals underscores the safety and efficacy of its AI-driven imaging solutions.
Opportunity Rollup
- Odds of Success
- 3.3
- Peak Market Share
- 3.9
- Segment CAGR
- 2.9%
- Market Segment
- Diagnostic Imaging
- Market Sub Segment
- AI-Powered Medical Imaging
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.20 |
| 2 | 0.58 |
| 3 | 1.36 |
| 4 | 2.73 |
| 5 | 3.90 |
Key Takeaway
Arterys, with its experienced team and innovative AI imaging solutions, is well-positioned in the growing diagnostic imaging market, despite facing significant competition and regulatory challenges.